Federated Hermes
RNAM

Federated Hermes’s Avidity Biosciences RNAM Stock Holding History

Federated Hermes’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,577
Closed -$45.9K – 2180
2024
Q4 		$45.9K Sell
1,577
-25,557
-94% -$1.07M ﹤0.01% 1689
2024
Q3 		$1.25M Buy
27,134
+23,871
+732% +$1.04M ﹤0.01% 1056
2024
Q2 		$133K Sell
3,263
-82
-2% -$2.35K ﹤0.01% 1537
2024
Q1 		$85.4K Buy
+3,345
New +$52.4K ﹤0.01% 1583
2023
Q4 		– Sell
-942
Closed -$6.01K – 2183
2023
Q3 		$6.01K Buy
+942
New +$8.12K ﹤0.01% 1868
2023
Q2 		– Sell
-2,363,600
Closed -$36.3M – 2212
2023
Q1 		$36.3M Hold
2,363,600
– – 0.09% 261
2022
Q4 		$52.4M Sell
2,363,600
-114,400
-5% -$1.71M 0.15% 178
2022
Q3 		$40.5M Buy
2,478,000
+3,500
+0.1% +$67K 0.12% 218
2022
Q2 		$36M Hold
2,474,500
– – 0.1% 256
2022
Q1 		$45.7M Hold
2,474,500
– – 0.1% 244
2021
Q4 		$58.8M Sell
2,474,500
-1,400
-0.1% -$33.4K 0.11% 241
2021
Q3 		$61M Buy
2,475,900
+504,984
+26% +$11M 0.12% 238
2021
Q2 		$48.7M Buy
1,970,916
+170,482
+9% +$3.97M 0.09% 286
2021
Q1 		$39.3M Buy
1,800,434
+368,834
+26% +$9.03M 0.08% 329
2020
Q4 		$36.5M Buy
1,431,600
+158,000
+12% +$4.61M 0.07% 312
2020
Q3 		$35.9M Buy
1,273,600
+902,681
+243% +$26.1M 0.08% 276
2020
Q2 		$10.5M Buy
+370,919
New +$10.7M 0.03% 528

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes's RNAM Position: Q1 2025 in Review

Federated Hermes sold out of Avidity Biosciences (RNAM) in Q1 2025, closing a stake of 1,577 shares — an estimated $45.9K sold.

Federated Hermes first reported a position in RNAM in Q2 2020 and held it in 17 quarters. The position peaked at $61M in Q3 2021. 220 funds tracked by Wall St. Rank hold RNAM as of Q1 2025.

  • Federated Hermes reported no remaining Avidity Biosciences position as of Q1 2025 after selling out during the quarter.
  • Federated Hermes sold 1,577 Avidity Biosciences shares in Q1 2025, an estimated $45.9K.
  • Federated Hermes first reported a position in Avidity Biosciences in Q2 2020 and held it in 17 quarters.
  • Federated Hermes's Avidity Biosciences position peaked at $61M in Q3 2021.
  • 220 funds tracked by Wall St. Rank held Avidity Biosciences as of Q1 2025.

Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.